Michael Stark: How Glucocorticoids in Pregnancy Affect Fetal Development and Why It Matters
Michael Stark, Professor of Neonatal Medicine and Deputy Director of Clinical Research at the Robinson Research Institute, Director of Neonatal Medicine at the University of Adelaide and Head of Neonatal Services at the Women’s and Children’s Hospital Adelaide, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Endocrine Reviews, adding:
“Our latest article about the critical role of glucocorticoids in pregnancy and the importance of understanding the underlying mechanisms of how they effect the fetus.
A significant step towards identifying ‘responsive subgroups‘ to optimise antenatal steroid therapy and move away from a simplistic one-size-fits-all approach to management of preterm birth.”
Title: Glucocorticoids in pregnancy: A master-switch for fetal maturation
Authors: Yoshi Tan, Michael J Stark, Vicki L Clifton, Michael D Wiese, Janna L Morrison, Kathryn L Gatford
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough